REP. BARTON LETTER TO FDA REQUESTS INFORMATION ON FTEs, RESOURCE ALLOCATION, DEVICE REVIEWS; ASKS "DOES FDA REGULATE THE PRACTICE OF MEDICINE?"
Rep. Barton (R-Tex.) is requesting that FDA supply total full-time equivalent personnel numbers for nine agency offices, with a breakdown of the number of total FTEs assigned to compliance, surveillance or supervision duties, as part of a lengthy list of information his House Commerce/Oversight & Investigations Subcommittee wants before its begins FDA oversight hearings.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth